Tuesday, April 2nd, is the fourth annual “Hope 42 Day”!!! Help us celebrate by supporting Hope for Two’s network connecting women who are currently pregnant with cancer with other women who have experienced a similar cancer diagnosis. Since 1997, we have provided information, hope, and support to more than 2,000 women from all 50 U.S. […]
Attached is an inspiring and informative video about a young woman, Gina Lawson, who has experienced a cancer diagnosis in pregnancy.
If you are pregnant and have been diagnosed with breast cancer, you are not alone. Every year, more than 1,000 women in the United States have breast cancer and are pregnant at the same time.
One out of every 1,000 pregnant women have cancer. It’s a situation that oncologists and OB/GYNs don’t often encounter, and one that can leave many women feeling very scared and alone, says Susan Musialowski, the patient coordinator for Hope for Two: The Pregnant With Cancer Network.
By: Elyce Cardonick, MD (published in Hopeline newsletter Fall 2013) Many women ask about the safety of breast feeding after a pregnancy complicated by cancer. Let me start by saying that if you do require any chemotherapy postpartum, unfortunately breast feeding is not advised once you start treatment. There are case reports of children having neutropenia […]
Fetal development is a complex process. At different stages of development, different aspects can be influenced by external factors (e.g., teratogenic drugs, alcohol, smoking, maternal stress, and altered nutrition). Among women in whom cancer is diagnosed during pregnancy, factors such as maternal illness, diagnostic tests, cancer treatment, and increased levels of maternal stress can negatively […]
Development of Children Born to Mothers with Cancer During Pregnancy: Comparing In Utero Chemotherapy-Exposed Children with Nonexposed Controls
The diagnosis of cancer during pregnancy creates medical and moral dilemmas for physicians and patients. Pregnant women are hesitant to receive chemotherapy due to concerns about possible effects on the developing fetus, while physicians are hesitant to allow pregnant women to delay cancer treatment for the remainder of the pregnancy.
The U.S. Food and Drug Administration published a final rule today that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products. The new content and formatting requirements will provide a more consistent way to include relevant information about the risks and benefits of […]